Ramelteon (TAK-375), A Selective MT1/MT2-Receptor Agonist, Reduces Latency to Persistent Sleep in a Model of Transient Insomnia Related to a Novel Sleep Environment
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: SLEEP
Authors: Thomas Roth, PhD, Charlene Stubbs, PhD, James K. Walsh, PhD
Language: English
Topic: Sleep and related disorders
Subfield: Experimental and Cognitive Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: closed
Funder: GlaxoSmithKline
OpenAlex ID: W2151602332